Candida Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital

Table 3

A multivariate regression analysis of Candida risk factors.

Variable	Infection outcome				Hospital outcome
	95% CI for OR				95% CI for OR
	Lower	Upper	value	OR	Lower	Upper	value	OR
Prior ICU admission (yes/no)	0.531	1.478	0.642	0.886	0.71	1.89	0.559	1.16
Neutropenia (yes/no)	0.218	1.936	0.439	0.65	0.29	2.01	0.585	0.76
Use of broad-spectrum antibiotic (yes/no)	0.948	3.609	0.071	1.849	1.74	5.77	<0.001	3.17
CV (yes/no)	1.269	3.631	0.004	2.146	1.22	3.26	0.006	1.99
TPN (yes/no)	0.286	1.085	0.085	0.557	0.56	1.86	0.944	1.02
Chemotherapy (yes/no)	0.267	2.683	0.778	0.847	0.33	2.61	0.887	0.93
Intra-abdominal infection (yes/no)	0.426	3.865	0.658	1.283	0.37	3.43	0.834	1.13
Chronic use of steroid (yes/no)	0.36	4.03	0.762	1.205	0.16	1.68	0.267	0.51
Immune-modulating drugs (yes/no)	0.285	5.194	0.792	1.216	0.16	2.55	0.527	0.64